Endocrinology, Diabetes & Metabolism Doctors in Corvallis, OR Accepting Medicare

5 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 5

Katy Jane Brown, D.O. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3517 Nw Samaritan Dr Ste 100, Corvallis, OR 97330 Phone: 541-768-4280

Dr. Susan Lynn Sanderson, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3680 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-754-1150    Fax: 808-775-9404

Dr. Patricia Shannon Hopson, DO Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3680 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-754-1260

Melanie A Jackson, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3615 Nw Samaritan Dr Ste 110, Corvallis, OR 97330 Phone: 541-768-7900

Dr. Tim Arakawa, MD, PHD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3615 Nw Samaritan Dr Ste G2, Corvallis, OR 97330 Phone: 541-768-7900

News Archive

Overall increase of cesarean births not due to maternal request

Fewer than two per cent of cesarean births in British Columbia were a result of maternal request, but the number of cesarean and assisted vaginal deliveries varied widely across health regions in B.C., according to a new study by University of British Columbia researchers.

Mallinckrodt receives FDA approval for 32 mg tablet strength of EXALGO

The U.S. Food and Drug Administration (FDA) has notified Mallinckrodt, the pharmaceuticals business of Covidien, that it has approved a 32 mg tablet strength of EXALGO (hydromorphone HCI) Extended-Release Tablets (CII) for opioid-tolerant patients with moderate-to-severe chronic pain requiring continuous around-the-clock opioid analgesia for an extended period of time.

New CRISPR-EZ method makes genome editing much easier in mice

University of California, Berkeley scientists have developed a quicker and more efficient method to alter the genes of mice with CRISPR-Cas9, simplifying a procedure growing in popularity because of the ease of using the new gene-editing tool.

Gilead Sciences signs definitive agreement to acquire Calistoga for $375 million

Gilead Sciences, Inc. and Calistoga Pharmaceuticals, Inc., a privately-held biotechnology company focused on the development of medicines to treat cancer and inflammatory diseases, today announced the signing of a definitive agreement pursuant to which Gilead will acquire Calistoga for $375 million.

Study investigates why American Indians with African ancestry were more fertile

American Indians with African ancestry outdid 'full bloods' in reproductive terms in the early 1900s, despite the odds being against them, according to a new study by Michael Logan from the University of Tennessee in the US. Their increased fertility occurred at a time when things were not going particularly well for full bloods either - in social, economic and health terms.

Read more Medical News

› Verified 3 days ago